Eli Lilly and Company logo

Eli Lilly and Company LLY

$ 905.03 -1.93%

Annual report 2025
added 02-12-2026

report update icon

Country

usaUSA

IPO year

-

Industry

Biotechnology

Stock Exchange

NYSESPB

Shares

897 M

Market Cap[1]

$ 812 B

EBITDA (LTM)

$ 2.37 B

P/E (LTM)

65.87

P/S (LTM)

15.91

EPS (LTM)

13.74

Eli Lilly and Company is one of the world's largest pharmaceutical companies, specializing in the development, manufacturing, and sale of innovative drugs for the treatment of various diseases.

The company was founded in 1876 in Indianapolis, Indiana and has since become a leader in the pharmaceutical industry. Eli Lilly and Company develops and manufactures a wide range of drugs, including those for diabetes, cancer, mental disorders, Alzheimer's disease, and other illnesses.

One of the company's most well-known developments is insulin, which was created in 1923. This drug became the first effective treatment for diabetes and has saved millions of lives worldwide.

Eli Lilly and Company actively invests in research and development of new drugs to help patients worldwide fight various diseases. The company also aims to improve the quality of life for patients by providing them with access to high-quality drugs. Is a global company with operations in more than 125 countries. The company cares about its employees and society as a whole, participating in various charitable projects and social responsibility programs.

Overall, is one of the most successful and innovative companies in the pharmaceutical industry. Its products help millions of people worldwide overcome difficulties associated with various diseases and improve their quality of life.

Other stocks of industry "Biotechnology"

Issuer Price % 24h Market Cap Exchange Country
Acorda Therapeutics Acorda Therapeutics
ACOR
- -24.86 % $ 820 K Nasdaq Global Select Market usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
- - $ 86.2 M Nasdaq Global Market usaUSA
MorphoSys AG MorphoSys AG
MOR
- 2.43 % $ 254 M Nasdaq Global Select Market germanyGermany
Burford Capital Limited Burford Capital Limited
BUR
$ 4.73 0.42 % $ 761 M NYSE britainBritain
Akouos Akouos
AKUS
- 0.23 % $ 488 M Nasdaq Global Select Market usaUSA
Alnylam Pharmaceuticals Alnylam Pharmaceuticals
ALNY
$ 333.39 -1.77 % $ 43.7 B Nasdaq Global Select Market,SPB usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
$ 3.17 3.93 % $ 5.22 M NYSE American israelIsrael
Applied Molecular Transport Applied Molecular Transport
AMTI
- - $ 10.1 M Nasdaq Global Select Market,SPB usaUSA
I-Mab I-Mab
IMAB
- - $ 866 M Nasdaq Global Select Market chinaChina
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
$ 3.73 3.04 % $ 8.97 B Nasdaq Capital Market australiaAustralia
AlloVir AlloVir
ALVR
- 4.14 % $ 49.1 M Nasdaq Global Select Market usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
- - $ 40.3 B Nasdaq Global Select Market usaUSA
Genfit SA Genfit SA
GNFT
- 2.54 % $ 160 B Nasdaq Global Select Market franceFrance
Biophytis SA Biophytis SA
BPTS
- -13.47 % $ 169 M Nasdaq Capital Market franceFrance
Aligos Therapeutics Aligos Therapeutics
ALGS
$ 7.42 -15.1 % $ 73.3 M Nasdaq Global Select Market usaUSA
Allakos Allakos
ALLK
- - $ 28.6 M Nasdaq Global Select Market,SPB usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
- - $ 7.46 M Nasdaq Global Market israelIsrael
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
- -1.52 % $ 24.7 M Nasdaq Capital Market usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
- -18.52 % $ 27.3 M Nasdaq Global Select Market britainBritain
Applied Therapeutics Applied Therapeutics
APLT
- - $ 8.42 M Nasdaq Global Market,SPB usaUSA
Aptinyx Aptinyx
APTX
- -39.0 % $ 4.57 M Nasdaq Global Select Market usaUSA
Aravive Aravive
ARAV
- -13.39 % $ 1.45 M Nasdaq Global Select Market usaUSA
Brainstorm Cell Therapeutics Brainstorm Cell Therapeutics
BCLI
- -2.5 % $ 5.88 M Nasdaq Capital Market usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
$ 21.68 1.4 % $ 1.01 B Nasdaq Global Select Market usaUSA
Cabaletta Bio Cabaletta Bio
CABA
$ 3.4 4.29 % $ 342 M Nasdaq Global Select Market usaUSA
CymaBay Therapeutics CymaBay Therapeutics
CBAY
- - $ 3.45 B Nasdaq Global Select Market usaUSA
BioNTech SE BioNTech SE
BNTX
$ 99.47 1.08 % $ 27.2 B Nasdaq Global Select Market germanyGermany
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
- - - MOEX russiaRussia
Advaxis Advaxis
ADXS
- -9.65 % $ 45.9 M Nasdaq Capital Market usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
- 5.93 % $ 314 M Nasdaq Capital Market canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
- -10.17 % $ 12.2 K NYSE American usaUSA
ContraFect Corporation ContraFect Corporation
CFRX
- -5.16 % $ 5.39 M Nasdaq Capital Market usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
- - $ 1.01 B Nasdaq Global Market usaUSA
Akebia Therapeutics Akebia Therapeutics
AKBA
- - $ 399 M Nasdaq Global Market usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
- - $ 26.5 M Nasdaq Global Select Market usaUSA
Aquestive Therapeutics Aquestive Therapeutics
AQST
$ 4.24 2.17 % $ 453 M Nasdaq Global Market usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
$ 24.58 -2.03 % $ 3.13 B Nasdaq Global Select Market,SPB usaUSA
AIkido Pharma AIkido Pharma
AIKI
- 1.93 % $ 17.4 M Nasdaq Capital Market usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
- -4.8 % $ 255 M Nasdaq Global Select Market usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
$ 1.49 0.68 % $ 397 M Nasdaq Global Select Market britainBritain
Aptose Biosciences Aptose Biosciences
APTO
- -45.71 % $ 1.2 M Nasdaq Capital Market canadaCanada
BeiGene, Ltd. BeiGene, Ltd.
BGNE
- 0.49 % $ 251 B Nasdaq Global Select Market cayman-islandsCayman-islands
Checkpoint Therapeutics Checkpoint Therapeutics
CKPT
- - $ 169 M Nasdaq Capital Market usaUSA
Caladrius Biosciences Caladrius Biosciences
CLBS
- -16.75 % $ 25.8 M Nasdaq Capital Market usaUSA
Celldex Therapeutics Celldex Therapeutics
CLDX
$ 33.87 1.62 % $ 2.25 B Nasdaq Global Select Market usaUSA
AVROBIO AVROBIO
AVRO
- 1083.1 % $ 745 M Nasdaq Global Select Market usaUSA
Clearside Biomedical Clearside Biomedical
CLSD
- - $ 25.3 M Nasdaq Global Market usaUSA
bluebird bio bluebird bio
BLUE
- - $ 546 M Nasdaq Global Select Market,SPB usaUSA
AstraZeneca PLC AstraZeneca PLC
AZN
- - $ 96.9 B Nasdaq Global Select Market britainBritain
Akero Therapeutics Akero Therapeutics
AKRO
- - $ 3.67 B Nasdaq Global Select Market,SPB usaUSA

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.